{"table_id": "Tab4", "table_label": "Table 4", "table_caption": "Changes in headache frequency, migraine frequency, and ASC-12 scores. Change in headache and migraine frequency compares weeks 5\u20138 after the first erenumab treatment to the 4-week pre-treatment period. Change in ASC-12 scores compares those obtained during the research visit at 8\u2009weeks after the first erenumab treatment to those collected just before the first treatment. ASC-12\u2009=\u2009Allodynia Symptom Checklist 12", "n_header_rows": 1, "table_data_file": "table_003.csv"}